Hypertrophic cardiomyopathy – symptomatic atrial fibrillation in a patient at high risk of sudden cardiac death

Journal Title: Journal of Rare Cardiovascular Diseases - Year 2019, Vol 4, Issue 1

Abstract

We present the case of a young patient with significant left ventricular hypertrophy as a common representation of the hypertrophic cardiomyopathy (HCM) phenotype. The clinical presentation and diagnostic route of the disease (despite negative genotype), which can be found in everyday cardiology practice, are shown. Despite the presence of guidelines on this topic, each clinical case is demanding, especially during qualification for invasive procedures. Limited data about the periprocedural risk of catheter ablation and success rate in HCM makes physician decisions for this type of patient challenging. The importance of informed consent and how the patient’s decisions affect further progress are also shown. JRCD 2018; 4 (1): 18–21

Authors and Affiliations

Adam Gębka, Renata Rajtar-Salwa, Marek Jastrzębski, Paweł Petkow-Dimitrow

Keywords

Related Articles

The 51‐year‐old patient with a non‐compaction cardiomiopathy and multi‐vessel coronary artery disease (RCD code: III-5A.1)

Left ventricular non-compaction (LVNC) or "spongy myocardium", is a rare form of a primary genetic cardiomyopathy considered to be the result of abnormal intrauterine arrest of the myocardial compaction process [1]. Left...

A 34‐year‐old man with non‐obstructive apical hypertrophic cardiomyopathy (RCD code: III‐2A.1)

Hypertrophic cardiomyopathy (HCM) is a primary disease of the myocardium that is defined by the presence of regional (more frequent) or global myocardial hypertrophy, which usually results in functional cardiac impairmen...

“One of the greatest disease is to be nobody to anybody”

Saint Mother Teresa of CalcuttaDear Readers,Before we go any further, try to ponder the quote once said by the Saint Teresa of Calcutta. She was by far one of the most entitled person in the world to say such an unpleasa...

Overlap cardiomyopathy – coexistence of hypertrophic and restrictive cardiomyopathy phenotypes in one patient (RCD code: III-2A.1)

Recent data indicate that substantial proportion of cardiomyopathy patients have in fact more than one phenotype, the phenomenon termed as overlap or mixed cardiomyopathy. The molecular mechanisms and pathology as well a...

Long term follow-up after the Ross procedure (RCD code: IV-5A.O)

Aims: The aim of this study was to analyze the incidence of long-term complications observed during follow-up of patients who had undergone the Ross procedure in childhood. Methods: The study engaged a cohort of 9 patien...

Download PDF file
  • EP ID EP563421
  • DOI 10.2041/jrcd.vol4no1.346
  • Views 99
  • Downloads 0

How To Cite

Adam Gębka, Renata Rajtar-Salwa, Marek Jastrzębski, Paweł Petkow-Dimitrow (2019). Hypertrophic cardiomyopathy – symptomatic atrial fibrillation in a patient at high risk of sudden cardiac death. Journal of Rare Cardiovascular Diseases, 4(1), 18-21. https://europub.co.uk/articles/-A-563421